6KLA
Crystal structure of human c-KIT kinase domain in complex with compound 15a
Summary for 6KLA
Entry DOI | 10.2210/pdb6kla/pdb |
Descriptor | Mast/stem cell growth factor receptor Kit, N-[6-(4-ethylpiperazin-1-yl)-2-methyl-pyrimidin-4-yl]-5-pyridin-4-yl-1,3-thiazol-2-amine (3 entities in total) |
Functional Keywords | tyrosine kinase inhibitor, kinase phosphorylation, atp competitor, transmembrane receptor protein, transferase |
Biological source | Homo sapiens (Human) More |
Total number of polymer chains | 1 |
Total formula weight | 38051.06 |
Authors | Wu, T.S.,Peng, Y.H.,Hsueh, C.C.,Wu, S.Y. (deposition date: 2019-07-30, release date: 2019-11-27, Last modification date: 2023-11-22) |
Primary citation | Lin, W.H.,Wu, S.Y.,Yeh, T.K.,Chen, C.T.,Song, J.S.,Shiao, H.Y.,Kuo, C.C.,Hsu, T.,Lu, C.T.,Wang, P.C.,Wu, T.S.,Peng, Y.H.,Lin, H.Y.,Chen, C.P.,Weng, Y.L.,Kung, F.C.,Wu, M.H.,Su, Y.C.,Huang, K.W.,Chou, L.H.,Hsueh, C.C.,Yen, K.J.,Kuo, P.C.,Huang, C.L.,Chen, L.T.,Shih, C.,Tsai, H.J.,Jiaang, W.T. Identification of a Multitargeted Tyrosine Kinase Inhibitor for the Treatment of Gastrointestinal Stromal Tumors and Acute Myeloid Leukemia. J.Med.Chem., 62:11135-11150, 2019 Cited by PubMed: 31721578DOI: 10.1021/acs.jmedchem.9b01229 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.109 Å) |
Structure validation
Download full validation report